Showing results (111-120 of 172) with videos related to

Sort By:
Pageof 18
Wellcome Open Research|October 4, 2024
VIVALDI Cohort Profile: Using linked, routinely collected data and longitudinal blood sampling to characterise COVID-19 infections, vaccinations, and related outcomes in care home staff and residents in EnglandMaria Krutikov, David Bone, Oliver Stirrup, et al.
Science Signaling|June 1, 2017
A disease-linked <i>ULBP6</i> polymorphism inhibits NKG2D-mediated target cell killing by enhancing the stability of NKG2D ligand bindingJianmin Zuo, Carrie R Willcox, Fiyaz Mohammed, et al.
Iscience|June 6, 2022
Machine learning of COVID-19 clinical data identifies population structures with therapeutic potentialDavid Greenwood, Thomas Taverner, Nicola J Adderley, et al.
Nature Communications|May 27, 2024
Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in EnglandEmma Copland, Martina Patone, Defne Saatci, et al.
Blood Advances|March 3, 2019
Mixed chimerism established by hematopoietic stem cell transplantation is maintained by host and donor T regulatory cellsFrancesca A M Kinsella, Jianmin Zuo, Charlotte F Inman, et al.
Hepatology (Baltimore, Md.)|April 18, 2012
Recruitment mechanisms of primary and malignant B cells to the human liverShishir Shetty, Tony Bruns, Christopher J Weston, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 26, 2021
Robust antibody responses in 70-80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021Sathyavani Subbarao, Lenesha A Warrener, Katja Hoschler, et al.
Open Forum Infectious Diseases|January 30, 2023
Clinical Effectiveness of SARS-CoV-2 Booster Vaccine Against Omicron Infection in Residents and Staff of Long-term Care Facilities: A Prospective Cohort Study (VIVALDI)Oliver Stirrup, Madhumita Shrotri, Natalie L Adams, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2022
COVID-19 therapeutics: Challenges and directions for the futurePhilip C Robinson, David F L Liew, Helen L Tanner, et al.
Nature Immunology|December 1, 2022
Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4<sup>+</sup> T cell recognitionEmily X C Tye, Elizabeth Jinks, Tracey A Haigh, et al.
Pageof 18